Children watch a series of short video scenes of social interactions while their looking behavior is monitored.
FDA-authorized EarliPoint captures and analyzes looking behavior imperceptible to the human eye.
With robust data empowering clinicians to reach a diagnosis with confidence and objectivity.
Most autism diagnosis methods rely on observations and parent interviews, which can mean a long wait for answers—sometimes until a child is 4 or 5 years old. That’s valuable brain development time lost. EarliPoint changes this. It is an objective, FDA-cleared tool that not only helps with early diagnosis, as young as 16 months, but also objectively tracks the child’s progress.
Be the first to know about upcoming events, research and case studies.